Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?
until further notice
SourceAmerican Journal of Physiology : Cell Physiology, 293, 1, (2007), pp. C22-9
Article / Letter to editor
Display more detailsDisplay less details
Paediatrics - OUD tm 2017
American Journal of Physiology : Cell Physiology
SubjectIGMD 8: Mitochondrial medicine; IGMD 9: Renal disorder; NCMLS 2: Metabolism, transport and motion; NCMLS 4: Energy and redox metabolism; UMCN 5.3: Cellular energy metabolism; UMCN 5.4: Renal disorders
Malfunction of NADH:ubiquinone oxidoreductase or complex I (CI), the first and largest complex of the mitochondrial oxidative phosphorylation system, has been implicated in a wide variety of human disorders. To demonstrate a quantitative relationship between CI amount and activity and mitochondrial shape and cellular reactive oxygen species (ROS) levels, we recently combined native electrophoresis and confocal and video microscopy of dermal fibroblasts of healthy control subjects and children with isolated CI deficiency. Individual mitochondria appeared fragmented and/or less branched in patient fibroblasts with a severely reduced CI amount and activity (class I), whereas patient cells in which these latter parameters were only moderately reduced displayed a normal mitochondrial morphology (class II). Moreover, cellular ROS levels were significantly more increased in class I compared with class II cells. We propose a mechanism in which a mutation-induced decrease in the cellular amount and activity of CI leads to enhanced ROS levels, which, in turn, induce mitochondrial fragmentation when not appropriately counterbalanced by the cell's antioxidant defense systems.
Upload full text